NHS England are reviewing prescribing in a number of areas and making recommendations to reduce the prescribing of certain items or to recommend using alternatives in the following instances:
- Items of low clinical effectiveness, where there is a lack of robust evidence of clinical effectiveness or there are significant safety concerns
- Items which are clinically effective but where more cost-effective products are available, this includes products that have been subject to excessive price inflation.
- Items which are clinically effective but due to the nature of the product, are deemed a low priority for NHS funding.
NHS England issued guidance on drugs of limited clinical value back in 2017 and they have just finished a further consultation on additional items which are included in the attached presentation.
When the CCG receive final guidance from NHS England members of the medications optimisation team will be coming out to district groups to discuss in the preparation of updating our local guidance. At the moment we do not have an anticipated date as to when the updated guidance will be released but as soon as it is available updates will be given.
document Online Consultation Programme (163 KB) - Sunil Sharma
pdf Community Pharmacy Presentation (1.61 MB) - Gill Hall, Service Development Office, South Staffs LPC
pdf Patient, Carer and Public Involvement and Engagement Presentation (1.10 MB) - Clinical Research Network